PLX Protalix Biotherapeutics, Inc.

Fundamentals / CIK 0001006281 / USD

Protalix Biotherapeutics, Inc. reported $84.69M in revenue and net income of $20.55M for the trailing twelve months ended September 30, 2026 (up 22.8% year over year), with a 71.2% gross margin and a 29.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PLX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$73.36M$36.68M$0-$83.58MFY 2016 Revenue: $9.20MFY 2016 Net Income: -$29.36M2016FY 2017 Revenue: $21.08MFY 2017 Net Income: -$83.44M2017FY 2018 Revenue: $34.24MFY 2018 Net Income: -$26.46M2018FY 2019 Revenue: $54.69MFY 2019 Net Income: -$18.28M2019FY 2020 Revenue: $62.90MFY 2020 Net Income: -$6.52M2020FY 2021 Revenue: $38.35MFY 2021 Net Income: -$27.58M2021FY 2022 Revenue: $47.64MFY 2022 Net Income: -$14.93M2022FY 2023 Revenue: $65.49MFY 2023 Net Income: $8.31M2023FY 2024 Revenue: $53.40MFY 2024 Net Income: $2.93M2024FY 2025 Revenue: $52.74MFY 2025 Net Income: -$6.60M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $52.74M $53.40M $65.49M $47.64M $38.35M $62.90M $54.69M $34.24M $21.08M $9.20M
Cost of Revenue $26.99M $24.32M $22.98M $19.59M $16.35M $10.87M $10.89M $9.30M $15.23M $8.40M
Gross Profit $25.75M $29.08M $42.51M $28.05M $22.00M $52.02M $43.80M $24.94M $4.01M $801K
Research & Development $19.57M $12.97M $17.09M $29.35M $29.73M $38.17M $44.62M $33.33M $32.17M $30.41M
Selling, General & Admin $11.68M $12.19M $14.96M $11.71M $12.73M $11.15M $9.90M $10.92M $11.53M $9.36M
Operating Income -$5.50M $3.92M $10.46M -$13.01M -$20.46M $2.71M -$10.72M -$19.31M -$34.52M -$33.16M
EBITDA -$4.04M $5.22M $11.65M -$11.93M -$19.34M $4.01M -$9.10M -$17.64M -$32.60M -$31.18M
Income Before Tax -$5.61M $4.15M $8.57M -$14.40M -$27.58M -$6.52M -- -- -- --
Income Tax Expense $996K $1.22M $254K $530K -- -- -- -- -- --
Net Income -$6.60M $2.93M $8.31M -$14.93M -$27.58M -$6.52M -$18.28M -$26.46M -$83.44M -$29.36M
Basic EPS -$0.08 $0.04 $0.12 -$0.31 -$0.62 -$0.22 -$1.23 -$1.80 -$6.37 -$2.90
Diluted EPS -$0.08 $0.04 $0.09 -$0.31 -$0.62 -$0.22 -$1.23 -$1.80 -$6.37 -$2.90
Basic Shares Outstanding 78.5M 72.5M 67.5M 48.5M 44.1M 29.1M 14.8M 14.7M 13.1M 10.1M
Diluted Shares Outstanding 78.5M 81.1M 82.4M 48.5M 44.1M 29.1M 14.8M 14.7M 13.1M 10.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $21.93M $19.90M $33.75M $9.12M $17.85M $15.66M $10.11M $18.22M
Cost of Revenue $7.88M $7.76M $4.13M $4.62M $8.32M $5.87M $8.18M $3.89M
Gross Profit $14.05M $12.13M $29.62M $4.50M $9.53M $9.79M $1.93M $14.33M
Research & Development $6.92M $4.35M $5.43M $5.63M $4.47M $5.99M $3.48M $4.12M
Selling, General & Admin $3.08M $3.11M $3.05M $3.53M $2.93M $2.62M $2.60M $3.00M
Operating Income $4.05M $4.67M $21.15M -$4.66M $2.13M $1.17M -$4.14M $7.21M
EBITDA $4.47M $5.08M $21.55M -$4.27M $2.50M $1.53M -$3.80M $7.54M
Income Before Tax $4.62M $4.86M $21.14M -$4.78M $2.24M $661K -$3.73M $7.32M
Income Tax Expense $661K $1.08M $2.82M $728K -$116K $497K -$113K $822K
Net Income $3.96M $3.78M $18.32M -$5.50M $2.35M $164K -$3.62M $6.49M
Basic EPS $0.05 $0.05 $0.23 -- $0.03 $0.00 -$0.05 --
Diluted EPS $0.05 $0.05 $0.22 -- $0.03 $0.00 -$0.05 --
Basic Shares Outstanding 80.5M 80.0M 79.8M -- 79.3M 78.7M 76.6M --
Diluted Shares Outstanding 83.6M 82.6M 83.0M -- 80.8M 81.3M 76.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $14.68M $19.76M $23.63M $17.11M $38.98M $18.27M $17.79M $37.81M $51.16M $63.28M
Cash & Short-Term Investments $14.68M $19.76M $23.63M $17.11M $38.98M $18.27M $17.79M $37.81M $51.16M $63.28M
Accounts Receivable, Net $8.84M $2.91M $5.27M $4.59M $3.44M $2.00M $4.70M $4.73M $1.72M $693K
Inventory $25.73M $21.24M $19.05M $16.80M $17.95M $13.08M $8.15M $8.57M $7.83M $5.25M
Other Current Assets $1.13M $1.10M $1.05M $1.31M $1.28M $2.10M $1.83M $1.88M $1.93M $2.65M
Total Current Assets $66.67M $60.08M $69.93M $44.88M $61.67M $55.72M $32.48M $52.98M $62.65M $71.87M
Property, Plant & Equipment, Net $4.88M $4.59M $4.97M $4.55M $4.96M $4.84M $5.27M $6.39M $7.68M $8.70M
Total Non-Current Assets $15.67M $13.34M $14.50M $10.91M $12.00M $12.21M $12.91M $8.15M $9.56M $10.38M
Total Assets $82.35M $73.42M $84.43M $55.79M $73.67M $67.93M $45.39M $61.13M $72.21M $82.25M
Accounts Payable $5.26M $4.53M $19.55M $12.27M $16.43M $13.93M $11.90M $10.27M $9.31M $7.50M
Deferred Revenue (Current) -- -- $0 $13.18M $8.55M $5.39M $16.34M $9.87M -- $837K
Total Current Liabilities $26.52M $25.62M $45.53M $32.43M $33.18M $86.47M $40.17M $25.35M $22.75M $66.21M
Deferred Revenue (Non-Current) -- -- -- $0 $11.79M $1.72M $16.98M $33.03M $25.02M --
Other Non-Current Liabilities -- -- -- -- -- $51K $509K $5.29M $5.05M $4.30M
Total Non-Current Liabilities $7.60M $4.58M $5.33M $34.00M $46.52M $8.50M $75.54M $88.66M $78.92M $25.99M
Total Liabilities $34.12M $30.21M $50.87M $66.43M $79.70M $94.97M $115.7M $114.0M $101.7M $92.20M
Total Debt (incl. Leases) $8.32M $5.53M $6.03M $5.29M $5.58M $5.89M $5.70M -- -- --
Common Stock $80K $76K $73K $54K $46K $35K $15K $15K $144K $124K
Retained Earnings -$385.0M -$378.4M -$381.5M -$389.9M -$374.9M -$347.4M -$340.8M -$322.6M -$296.1M -$212.7M
Total Stockholders' Equity $48.23M $43.21M $33.57M -$10.64M -$6.04M -$27.04M -$70.32M -$52.88M -$29.46M -$9.96M
Total Equity $48.23M $43.21M $33.57M -$10.64M -$6.04M -$27.04M -$70.32M -$52.88M -$29.46M -$9.96M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $22.04M $27.42M $41.00M $14.68M $13.65M $17.89M $19.46M $19.76M
Cash & Short-Term Investments $22.04M $27.42M $41.00M $14.68M $13.65M $17.89M $19.46M $19.76M
Accounts Receivable, Net $13.91M $16.50M $2.94M $8.84M $14.43M $9.44M $4.67M $2.91M
Inventory $34.30M $32.29M $30.47M $25.73M $21.25M $21.13M $19.51M $21.24M
Other Current Assets $1.40M $2.05M $1.15M $1.13M $1.45M $1.51M $1.59M $1.10M
Total Current Assets $98.87M $92.22M $86.36M $66.67M $66.50M $65.48M $60.51M $60.08M
Property, Plant & Equipment, Net $5.77M $5.47M $5.15M $4.88M $4.72M $4.75M $4.72M $4.59M
Total Non-Current Assets $19.37M $18.12M $15.98M $15.67M $15.76M $13.00M $13.38M $13.34M
Total Assets $118.2M $110.3M $102.3M $82.35M $82.26M $78.49M $73.89M $73.42M
Accounts Payable $4.78M $6.51M $4.29M $5.26M $5.38M $6.69M $4.12M $4.53M
Total Current Liabilities $30.23M $31.39M $27.39M $26.52M $21.95M $24.09M $24.32M $25.62M
Total Non-Current Liabilities $7.46M $7.54M $7.72M $7.60M $7.41M $4.49M $4.36M $4.58M
Total Liabilities $37.69M $38.93M $35.11M $34.12M $29.36M $28.58M $28.68M $30.21M
Total Debt (incl. Leases) $9.14M $9.21M $8.48M $8.32M $8.18M $5.35M $5.24M $5.53M
Common Stock -- -- -- $80K -- -- -- $76K
Retained Earnings -- -- -- -$385.0M -- -- -- -$378.4M
Total Stockholders' Equity $80.55M $71.40M $67.23M $48.23M $52.91M $49.90M $45.21M $43.21M
Total Equity $80.55M $71.40M $67.23M $48.23M $52.91M $49.90M $45.21M $43.21M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$6.60M $2.93M $8.31M -$14.93M -$27.58M -$6.52M -$18.28M -$26.46M -$83.44M -$29.36M
Depreciation & Amortization $1.47M $1.30M $1.19M $1.09M $1.12M $1.30M $1.62M $1.67M $1.92M $1.98M
Stock-Based Compensation $2.30M $3.25M $3.45M $2.08M $2.38M $3.13M $835K $514K $337K $988K
Change in Receivables -$5.89M $2.32M -$428K -$1.19M -$1.03M $2.09M $188K -$3.10M $25K -$1.13M
Change in Inventory -$4.49M -$2.20M -$2.24M $1.15M -$4.87M -$4.93M $414K -$736K -$2.59M $522K
Operating Cash Flow -$11.99M $8.67M -$1.32M -$25.00M -$10.29M -$26.11M -$19.36M -$7.74M -$9.99M -$32.10M
Capital Expenditure -$1.64M -$1.28M -$1.15M -$628K -$1.46M -$655K -$627K -$686K -$971K -$849K
Free Cash Flow -$13.63M $7.39M -$2.47M -$25.63M -$11.74M -$26.76M -$19.98M -$8.43M -$10.96M -$32.95M
Investing Cash Flow -$2.37M $4.22M -$16.71M -$5.04M $18.92M -$19.95M -$883K -$591K -$1.12M -$967K
Common Stock Issued $6.81M $3.63M $23.95M $8.24M $8.57M $4.87M -- -- -- --
Financing Cash Flow $9.33M -$16.79M $24.67M $8.24M $12.08M $46.47M $0 -$4.75M -$1.42M $19.70M
Net Change in Cash -$5.08M -$3.87M $6.52M -$21.87M $20.72M $473K -$20.02M -$13.36M -$12.12M -$13.09M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $3.96M $3.78M $18.32M -$5.50M $2.35M $164K -$3.62M $6.49M
Depreciation & Amortization $421K $406K $404K $387K $372K $360K $346K $334K
Stock-Based Compensation $601K $398K $532K $732K $598K $427K $540K $654K
Change in Receivables $3.26M -$15.03M $6.41M $5.88M -$4.85M -$4.64M -$2.27M -$752K
Change in Inventory -$2.00M -$1.82M -$4.75M -$4.47M -$124K -$1.62M $1.74M -$4.04M
Operating Cash Flow $3.90M -$10.40M $22.02M $2.03M -$3.73M -$5.23M -$5.06M $3.99M
Capital Expenditure -$737K -$593K -$761K -$403K -$498K -$431K -$306K -$425K
Free Cash Flow $3.17M -$10.99M $21.26M $1.63M -$4.23M -$5.66M -$5.36M $3.57M
Investing Cash Flow -$13.81M -$3.63M $4.22M -$1.11M -$504K -$438K -$312K -$15.32M
Common Stock Issued -- -- -- $0 $0 $3.95M $2.86M --
Financing Cash Flow $4.58M $0 $150K $146K $0 $4.10M $5.08M --
Net Change in Cash -$5.38M -$13.58M $26.32M $1.03M -$4.25M -$1.56M -$302K -$7.65M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 48.8% 54.5% 64.9% 58.9% 57.4% 82.7% 80.1% 72.8% 19.0% 8.7%
Operating Margin -10.4% 7.3% 16.0% -27.3% -53.4% 4.3% -19.6% -56.4% -163.8% -360.5%
Net Profit Margin -12.5% 5.5% 12.7% -31.3% -71.9% -10.4% -33.4% -77.3% -395.9% -319.2%
Return on Equity (ROE) -13.7% 6.8% 24.8% -- -- -- -- -- -- --
Return on Assets (ROA) -8.0% 4.0% 9.8% -26.8% -37.4% -9.6% -40.3% -43.3% -115.5% -35.7%
Current Ratio 2.51x 2.34x 1.54x 1.38x 1.86x 0.64x 0.81x 2.09x 2.75x 1.09x
Quick Ratio 1.54x 1.52x 1.12x 0.87x 1.32x 0.49x 0.61x 1.75x 2.41x 1.01x
Debt to Equity 0.17x 0.13x 0.18x -- -- -- -- -- -- --
Revenue Growth (YoY) -1.2% -18.5% +37.5% +24.2% -39.0% +15.0% +59.7% +62.4% +129.1% +110.8%
Gross Profit Growth (YoY) -11.4% -31.6% +51.6% +27.5% -57.7% +18.8% +75.6% +521.7% +400.7% -78.0%
Operating Income Growth (YoY) -240.4% -62.6% -- -- -855.1% -- -- -- -- --
Net Income Growth (YoY) -325.2% -64.7% -- -- -- -- -- -- -- -150.6%
EPS Growth (YoY) -300.0% -66.7% -- -- -- -- -- -- -- -147.5%
Operating Cash Flow Growth (YoY) -238.3% -- -- -- -- -- -- -- -- --
Free Cash Flow Growth (YoY) -284.4% -- -- -- -- -- -- -- -- --
5Y Revenue / Share Growth -68.9% -80.0% -58.3% -38.9% -4.2% +369.4% +871.9% -- -58.1% -8.4%
10Y Revenue / Share Growth +46.1% +94.1% -- -74.4% -12.3% +163.0% -- -- -- --
5Y Net Income / Share Growth -- -- -- -- -- -103.7% -- -- -- --
10Y Net Income / Share Growth -101.4% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 71.2% 69.2% 70.0% 48.8% 57.5% 57.5% 50.0% 54.5%
Operating Margin 29.8% 28.9% 25.9% -10.4% 10.3% 13.3% 7.7% 7.3%
Net Profit Margin 24.3% 23.5% 20.1% -12.5% 8.7% 10.1% 6.5% 5.5%
Return on Equity (ROE) 25.5% 26.5% 22.8% -13.7% 10.2% 12.6% 8.6% 6.8%
Return on Assets (ROA) 17.4% 17.2% 15.0% -8.0% 6.6% 8.0% 5.3% 4.0%
Current Ratio 3.27x 2.94x 3.15x 2.51x 3.03x 2.72x 2.49x 2.34x
Quick Ratio 2.14x 1.91x 2.04x 1.54x 2.06x 1.84x 1.69x 1.52x
Debt to Equity 0.11x 0.13x 0.13x 0.17x 0.15x 0.11x 0.12x 0.13x
Revenue Growth (YoY) +22.8% +27.1% +233.7% -49.9% -0.6% +16.2% +169.8% +73.7%
Gross Profit Growth (YoY) +47.5% +24.0% +1432.5% -68.6% -0.6% +143.6% +68.7% +779.3%
Operating Income Growth (YoY) +89.9% +298.6% -- -164.6% -46.6% -- -- --
Net Income Growth (YoY) +68.2% +2203.0% -- -184.8% -27.2% -- -- --
EPS Growth (YoY) +66.7% -- -- -- -25.0% -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -49.1% -190.9% -- -220.8% +11.0%
Free Cash Flow Growth (YoY) -- -- -- -54.4% -205.3% -- -249.4% +6.6%
Source: SEC EDGAR CompanyFacts (CIK 0001006281) · from December 31, 2009 Data through September 30, 2026 · synced Nov 20, 2026, 05:43 UTC · Open in terminal